ID   SK-MEL-34
AC   CVCL_8084
SY   SK-Mel-34; BA-Mel
DR   Cosmic; 721842
DR   Wikidata; Q54954092
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=1067619;
RX   PubMed=3518877;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 14
//
RX   DOI=10.1007/978-1-4615-7228-2_39;
RA   Houghton, Alan N.
RA   Oettgen, Herbert Friedrich
RA   Old, Lloyd John
RT   "Malignant melanoma. Current status of the search for melanoma-specific
RT   antigens.";
RL   (In book chapter) Immunodermatology. Comprehensive Immunology, Vol 7; Safai, Bijan & Good, Robert Alan (eds.); pp.557-576; Springer; Boston; USA (1981).
//
RX   PubMed=1067619; DOI=10.1073/pnas.73.9.3278; PMCID=PMC431008;
RA   Carey, Thomas E.
RA   Takahashi, Toshitada
RA   Resnick-Silverman, Lois A.
RA   Oettgen, Herbert Friedrich
RA   Old, Lloyd John
RT   "Cell surface antigens of human malignant melanoma: mixed
RT   hemadsorption assays for humoral immunity to cultured autologous
RT   melanoma cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 73:3278-3282(1976).
//
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh, Jorgen
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
//